The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
unfortunately uh lopa transformed to dopamine also binds dopamine receptors in the reward pathway which is why about a quarter of folks with Parkinson's who get treated with lopa end up with uh addictive disorders that are usually uh reversible when you stop the lopa and tend to be um dose dependent
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.